Burning Rock Biotech (BNR) EBIT (2020 - 2025)
Historic EBIT for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to -$2.3 million.
- Burning Rock Biotech's EBIT rose 5878.18% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.2 million, marking a year-over-year increase of 7212.2%. This contributed to the annual value of -$49.0 million for FY2024, which is 4803.6% up from last year.
- Latest data reveals that Burning Rock Biotech reported EBIT of -$2.3 million as of Q3 2025, which was up 5878.18% from -$1.6 million recorded in Q2 2025.
- In the past 5 years, Burning Rock Biotech's EBIT registered a high of -$1.6 million during Q2 2025, and its lowest value of -$41.5 million during Q1 2022.
- For the 5-year period, Burning Rock Biotech's EBIT averaged around -$22.0 million, with its median value being -$24.5 million (2023).
- Per our database at Business Quant, Burning Rock Biotech's EBIT tumbled by 20269.9% in 2021 and then surged by 8951.25% in 2025.
- Burning Rock Biotech's EBIT (Quarter) stood at -$39.6 million in 2021, then rose by 20.32% to -$31.5 million in 2022, then grew by 25.69% to -$23.4 million in 2023, then surged by 52.09% to -$11.2 million in 2024, then skyrocketed by 79.8% to -$2.3 million in 2025.
- Its last three reported values are -$2.3 million in Q3 2025, -$1.6 million for Q2 2025, and -$2.1 million during Q1 2025.